Streptococcus Agalactiae (GBS) screening

Streptococcus Agalactiae (GBS) screening is a laboratory test used to detect the bacteria Streptococcus Agalactiae, which can cause infections in people of all ages, but particularly poses risks for pregnant women and newborns. Our expert team at IntroLab laboratory, consisting of experienced microbiologists and technicians, conducts GBS analysis. Our team is dedicated to providing the most accurate and reliable results.

What is Streptococcus Agalactiae?

Streptococcus Agalactiae, also known as Group B Streptococcus (GBS), is a type of bacteria that can naturally be found in the digestive tract and the genital tract of some individuals. Although it is harmless in most people, GBS can cause serious infections, especially in newborns, the elderly, and individuals with weakened immune systems.

In pregnant women, GBS is particularly important because it can be transmitted from mother to baby during childbirth. GBS infection in newborns can lead to serious conditions such as sepsis, meningitis, or pneumonia. For this reason, women are often tested for GBS during pregnancy, usually between the 35th and 37th weeks. If a woman is found to be a carrier of GBS, doctors can take appropriate measures, such as administering antibiotics during labor, to reduce the risk of transmitting the bacteria to the baby.

What preparation is needed for Streptococcus Agalactiae (GBS) screening?

Preparation for the GBS analysis is simple and does not require special preparations. The analysis is typically conducted using a vaginal or rectal swab.

Are there any specific aspects or subtypes of the analysis?

The GBS analysis is specific in that it is based on bacterial culture. Other tests can also be used to detect GBS, such as PCR tests, but culture is considered the gold standard.